Try putting Race Oncology against Keytruda, you’ll see in relative terms how frequent the searches are. Past 90 days in the US, the best RAC achieves is 8% compared to Keytruda’s 100% maximum.
I wouldn’t suggest that means that big pharma is searching RAC for DD purposes, but it could indicate the information has spilled out of such a process, or simply the news has reached the US via Open Source means, e.g. media, word of mouth etc.
At this point I’d argue it’s more likely anyone in the US would find Bisantrene before RAC, simply because the COH results mention Bisantrene, not RAC.
Last edited by jamiedc:
For typo - it’s late.09/03/21
RAC Price at posting:
$3.73 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)